$113.52
-0.50-0.44%
Last update: Nov 10, 4:00 PM
Agilon Health Inc
AGLNYSE
Agilon Health rose 637.2% from $15.47 to $114.02, ahead of the S&P 500's +9.8%. Its worst day was Feb 10 (−26.8%), and its low came Mar 31 at $7.91.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Agilon Health shares fell 26.8%, while the S&P 500 fell 0.3%.
−26.8%, the year's worst day · S&P 500 −0.3%
EPS of $-11.50 missed the $-6.75 estimate on $1.6B revenue (est. $1.5B); FY revenue guidance of $5.4B–$5.6B against the $6.0B consensus.
Story events cover the past 12 months · Times ET
+18.9% · S&P 500 −0.6%
Agilon Health closed at its lowest level of the year, 48.9% below where the year started.
−1.6% · S&P 500 +2.9%
EPS of $1.80 beat the $0.95 estimate on $1.4B revenue (est. $1.4B); FY revenue guidance of $5.7B–$5.8B against the $5.5B consensus.
+117.8%, the year's best day, on 4M shares, the year's heaviest volume · S&P 500 −0.3%
Agilon Health closed at its highest level of the year, 739.4% above where the year started.
+7.1% · S&P 500 −1.0%
EPS of $1.04 beat the $0.14 estimate on $1.5B revenue (est. $1.4B); Q3 revenue guidance of $1.4B–$1.5B against the $1.4B consensus.
−19.5% · S&P 500 −0.2%
EPS of $1.97 beat the $-0.99 estimate on $1.5B revenue (est. $1.5B); FY revenue guidance of $5.9B–$5.9B against the $5.8B consensus.
+18.2% · S&P 500 −4.4%
Where it ended: a close of $114.02 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $-2.72, revenue est. $1.5B).
Nothing in the past 12 months.
All AGL dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AGL and SPY from Benzinga historical bars. Not investment advice.
